BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 44 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $7,875,000 | -0.5% | 6,000,000 | -20.0% | 0.36% | -11.4% |
| Q1 2020 | $7,916,000 | -0.1% | 7,500,000 | +2.7% | 0.40% | +25.5% |
| Q4 2019 | $7,920,000 | +5.2% | 7,300,000 | 0.0% | 0.32% | +0.3% |
| Q3 2019 | $7,528,000 | -8.4% | 7,300,000 | 0.0% | 0.32% | -11.1% |
| Q2 2019 | $8,214,000 | -1.1% | 7,300,000 | 0.0% | 0.36% | -4.8% |
| Q1 2019 | $8,303,000 | +2.3% | 7,300,000 | 0.0% | 0.38% | -10.2% |
| Q4 2018 | $8,119,000 | -7.2% | 7,300,000 | 0.0% | 0.42% | +6.0% |
| Q3 2018 | $8,749,000 | -7.1% | 7,300,000 | -9.9% | 0.40% | -15.5% |
| Q2 2018 | $9,414,000 | +287.2% | 8,100,000 | +268.2% | 0.47% | +267.2% |
| Q1 2018 | $2,431,000 | -35.5% | 2,200,000 | -37.1% | 0.13% | -68.0% |
| Q4 2013 | $3,769,000 | – | 3,500,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 4,885,000 | $5,468,000 | 0.79% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 23,153,000 | $25,858,000 | 0.62% |
| RWC Asset Management LLP | 7,300,000 | $8,119,000 | 0.42% |
| IRON Financial LLC | 460,000 | $513,000 | 0.40% |
| Calamos Advisors LLC | 47,578,000 | $53,058,000 | 0.35% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 7,175,000 | $7,979,000 | 0.28% |
| Calamos Wealth Management LLC | 1,370,000 | $1,528,000 | 0.23% |
| SSI INVESTMENT MANAGEMENT LLC | 1,835,000 | $2,043,000 | 0.19% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,120,000 | $14,628,000 | 0.13% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,221,000 | $3,613,000 | 0.13% |